Alcon Basic EPS 2019-2024 | ALC
Alcon annual/quarterly basic eps history and growth rate from 2019 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Alcon basic eps for the quarter ending September 30, 2024 was $0.53, a 29.27% increase year-over-year.
- Alcon basic eps for the twelve months ending September 30, 2024 was $2.36, a 162.22% increase year-over-year.
- Alcon annual basic eps for 2023 was $0.002B, a 191.18% increase from 2022.
- Alcon annual basic eps for 2022 was $0.001B, a 11.69% decline from 2021.
- Alcon annual basic eps for 2021 was $0.001B, a 170.64% decline from 2020.
| Alcon Annual Basic EPS | |
|---|---|
| 2023 | $1.98 |
| 2022 | $0.68 |
| 2021 | $0.77 |
| 2020 | $-1.09 |
| 2019 | $-1.34 |
| 2018 | $-0.46 |
| Alcon Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | $0.53 |
| 2024-06-30 | $0.45 |
| 2024-03-31 | $0.50 |
| 2023-12-31 | $0.88 |
| 2023-09-30 | $0.41 |
| 2023-06-30 | $0.34 |
| 2023-03-31 | $0.35 |
| 2022-12-31 | $-0.20 |
| 2022-09-30 | $0.24 |
| 2022-06-30 | $0.30 |
| 2022-03-31 | $0.34 |
| 2021-12-31 | $0.29 |
| 2021-09-30 | $0.00 |
| 2021-06-30 | $0.31 |
| 2021-03-31 | $0.17 |
| 2020-12-31 | $0.19 |
| 2020-09-30 | $-0.30 |
| 2020-06-30 | $-0.86 |
| 2020-03-31 | $-0.12 |
| 2019-12-31 | $-0.18 |
| 2019-09-30 | $-0.14 |
| 2019-06-30 | $-0.80 |
| 2019-03-31 | $-0.22 |
| 2018-12-31 | |
| 2018-09-30 | $-0.42 |
| 2018-06-30 | $0.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.207B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.408B | 24.08 |
| Intuitive Surgical (ISRG) | United States | $196.120B | 102.54 |
| Edwards Lifesciences (EW) | United States | $41.510B | 26.36 |
| IQVIA Holdings (IQV) | United States | $35.864B | 19.76 |
| IDEXX Laboratories (IDXX) | United States | $34.273B | 40.36 |
| DexCom (DXCM) | United States | $29.084B | 43.80 |
| Waters (WAT) | United States | $21.880B | 32.35 |
| STERIS (STE) | Ireland | $21.298B | 24.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.458B | 0.00 |
| Hologic (HOLX) | United States | $18.284B | 19.29 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.898B | 13.24 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.562B | 29.28 |
| Penumbra (PEN) | United States | $9.230B | 90.41 |
| Masimo (MASI) | United States | $9.055B | 43.81 |
| Teleflex (TFX) | United States | $8.854B | 14.12 |
| Glaukos (GKOS) | United States | $7.765B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.929B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| Veracyte (VCYT) | United States | $3.018B | 90.56 |
| Inari Medical (NARI) | United States | $2.913B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.807B | 16.21 |
| TransMedics (TMDX) | United States | $2.663B | 84.40 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 18.44 |
| Elekta AB (EKTAY) | Sweden | $2.125B | 17.31 |
| Tandem Diabetes Care (TNDM) | United States | $2.019B | 0.00 |
| RxSight (RXST) | United States | $1.816B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.775B | 9.27 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Artivion (AORT) | United States | $1.175B | 77.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.992B | 0.00 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.828B | 14.08 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.714B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.548B | 12.91 |
| SiBone (SIBN) | United States | $0.515B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 32.40 |
| Tactile Systems Technology (TCMD) | United States | $0.383B | 20.70 |
| CVRx (CVRX) | United States | $0.358B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.315B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| NeuroPace (NPCE) | United States | $0.269B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.150B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.67 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |